NASAL DUO ACTIVE 1,0/50 mg/ml Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

nasal duo active 1,0/50 mg/ml

teva pharmaceuticals slovakia s.r.o., slovensko - xylometazolín - 69 - otorhinolaryngologica

NASAL DUO ACTIVE 0,5/50 mg/ml Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

nasal duo active 0,5/50 mg/ml

teva pharmaceuticals slovakia s.r.o., slovensko - xylometazolín - 69 - otorhinolaryngologica

COVID-19 Vaccine (inactivated, adjuvanted) Valneva Európska únia - slovenčina - EMA (European Medicines Agency)

covid-19 vaccine (inactivated, adjuvanted) valneva

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vakcíny - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Európska únia - slovenčina - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - chrípky vírusu povrchové antigény (hemaglutinínu a neuraminidázy) kmeňa a/vietnam/1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vakcíny - aktívna imunizácia proti podtypu h5n1 vírusu chrípky a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.